(AAPL) Apple has 6 more days to reach an agreement with Cisco over the iPhone trademark.
(ADM) Archer Daniels Midland priced $1.15B in notes and will repurchase more than $350M in common stock.
(AMR) AMR up 9% pre-market after Business Week noted it could be acquired for $46 to $52; Reuters reports that British Air and Goldman Sachs are not planning to bid.
(BPT) Prudhoe Bay noted as a SELL on Cramer’s MAD MONEY.
(BUCY) Bucyrus reports this morning.
(CAE) Cascade will replace ELK in the S&P Small Cap 600 Index.
(CBSS) COMPASS BANK UP 7% AFTER BEING ACQUIRED BY BBVA in Spain.
(CECO) Career Education trading down 12% after earnings yesterday.
(CPB) Campbell soup reports this morning.
(CMG) Chipotle traded up 4% after beating earnings.
(CPKI) California Pizza Kitchen $0.19 EPS vs $0.16e.
(DRTE) Dendrite posted a loss buyt reaffirmed 2007 targets.
(EL) Estee Lauder approved a 20M share buyback plan.
(FPIC)) FPIC INSURANCE reports this morning.
(FRO) Frontline noted as a SELL on Cramer’s MAD MONEY.
(FRNT) Frontier Airlines announced pilots agreed to new contract.
(GOOG) Google bought private Adscape for video game advertising for $23 million according to Red Herring.
(GT) Goodyear Tire reports this morning.
(HON) Honeywell announced a $3 Billion stock buyback plan, close to 8% of the stock.
(HRL) Hormel $0.57 EPS vs $0.58e.
(ICGE) INternet Capital reports this morning.
(ISV) Inspire wins 413M payment in pact with Insite Vision plus $19M milestone.
(KNDL) Kendle $0.18 EPS vs $0.17e.
(LMS) Lamson & Sessions reports this morning.
(LOOK) Looksmart traded down 1.5% after beating EPS targets, but missed revenues and guided revenues down.
(MSFT) Microsoft trading down 1.4% after Ballmer noted some analyst expectations were too high for Vista at analyst meeting.
(MYL) Mylan Labs announced final FDA approval for propranolol hydrochloride extended-release capsules.
(NABI ) Nabi Bio chairman resigned.
(SJM) JM Smucker $0.72 EPS vs $0.69e.
(SMDI) Sirenza Micro founder and wife are selling 7M shares of common stock.
(SPPI) Spectrum Pharmaceuticals announces completion of NDA filing for satraplatin for hormone refractory prostate cancer
(VC) Visteon reported -$0.31 EPS but had huge gains and huge charges; estimates were -$0.80; sees challenges continuing.
(WYE) Wyeth announced that a Federal Jury rules for Wyeth in hormone replacement trial.
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
